RNRicardo Pasquini Neto

Ricardo Pasquini Neto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ricardo Pasquini Neto has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pancitopenia como apresentação inicial de anemia perniciosa: relato de caso de uma abordagem minimamente invasiva

    by Mariana Cristina Gomes-Morila, Ricardo Pasquini-Neto, Lucas Latchuk Martins, Lucas Wagner Gortz, Guilherme Augusto Nazar, Maurício de Carvalho

    A pancitopenia frequentemente é associada a neoplasias comprometedoras da medula óssea, falências medulares e infecções. Sua manifestação associada a deficiência de vitamina B12 apesar de rara, também pode ser encontrada. Ao pensar nos diagnósticos diferenciais, a hipovitaminose deve ser considerada para reduzir a exposição do paciente à investigação invasiva e de alto custo. Nesse contexto, o presente relato de caso buscou apresentar uma abordagem minimamente invasiva para o diagnóstico da anemia perniciosa com inicial apresentação de pancitopenia.

  • Open Access

    Fertility Does not Quarantine: Coronavirus Disease 2019 Pandemic Impacts on in Vitro Fertilization Clinical Pregnancy Rates

    by Fernanda de Almeida Vieira, Ricardo Pasquini Neto, Mariana Cristina Gomes Morila, Jean Borges Curimbaba, Daniela Sasso Pasquini, Paulo Cesar Zimmermann Felchner, Gustavo Wandresen, Jan Pawel Andrade Pachnicki

    Objective To understand the impact of the coronavirus disease 2019 pandemic on in vitro fertilization (IVF) clinical pregnancy rates and analyze factors that may have influenced their outcome. Methods This was a retrospective observational study conducted at a tertiary-care Brazilian fertility center. All fresh IVF and embryo warming cycles performed from March 11 to December 31, 2018–2021 were analyzed, and their data were used to calculate fertilization, embryo cleavage, cycle cancellation, embryo transfer (ET), and clinical pregnancy rates. Statistical tests were used to evaluate the alterations found. Logistic regression models were used to explore the association of the categorical variables with the observed clinical pregnancy rates. Data from 2018 and 2019 (prepandemic) and 2020 and 2021 (pandemic) were grouped. Results A total of 756 cycles were analyzed (n = 360 prepandemic and n = 396 pandemic). The age group of the patients, fertilization rates, and cleavage rates did not have significant differences (p > 0.05). There was a reduction in the percentage of fresh IVF and an increase in embryo warming cycles (p = 0.005) during the pandemic. There was also an increase in fresh cycle cancellations (p < 0.001) and a reduction in ET rates (p < 0.001). The pandemic had a negative impact on clinical pregnancy rates (p < 0.001) especially due to the increase in fresh cycle cancellations (p < 0.001). Conclusion Embryo warming cycles with subsequent frozen-thawed ET were presented as a viable alternative to continue assisted reproductive treatments against pandemic restrictions on fresh cycles, ensuring clinical pregnancy, albeit at a lower rate than that of the prepandemic period.


  • Open Access

    Hemophagocytic lymphohistiocytosis: a case series analysis in a pediatric hospital

    by Itallo Oliveira Santos, Ricardo Pasquini Neto, Ana Paula Kuczynski Pedro Bom


  • Open Access

    Primary Small Bowel Amelanotic Melanoma and Intestinal Intussusception: A Case Report

    by Vitor Machado Guimbala, Raul Francisco Kormann, Plínio Cézar Neto, João Gabriel Vicentini Karvat, Ricardo Pasquini Neto, João Victor Pruner Vieira, Maria Cristina Figueroa Magalhães

    Primary gastrointestinal melanomas (PGM) are usually asymptomatic in the early stages, leading to misdiagnosis. We reported the case of a 75-year-old male patient admitted to our service due to hematochezia, and fatigue. Primary investigation showed small bowel intussusception and surgical treatment was performed. Histopathology and immunohistochemistry analysis identified primary small bowel amelanotic melanoma at an advanced tumor stage. Whereas the patient had a sudden impairment of performance status during hospitalization, no curative oncological approach could be performed. This report highlights the clinical and imaging findings that led to the primary gastrointestinal amelanotic melanoma diagnosis in an elderly patient with intestinal intussusception. The early recognition of prior intussusception signs in adults and elder patients may lead to an earlier oncological diagnosis and a better prognosis.

  • Open Access

    Autologous Anti-CD19 CAR T-Cells immunotherapy in relapsed/refractory acute lymphoblastic leukemia patients. A systematic review and meta-analysis

    by Ricardo Pasquini Neto, Felipe Antonio Torres Mazzo, Gustavo de Souza Bueno, João Vitor Correa Previdi, Nasthia Kreuz Baziulis da Silva, Tulio da Silva Vieira, Maria Cristina Figueroa Magalhães

    Introduction: Acute Lymphoblastic Leukemia (ALL) is the most prevalent malignancy in children; however, when the neoplasm becomes refractory/relapses (R/R) the cure possibilities are practically null. Objectives: To analyze the Anti-CD19 Chimeric Antigen Receptors (CAR) T-Cells immunotherapy efficacy in the treatment of R/R ALL, providing evidence about the efficacy and safety of the therapy for the analyzed group. Methods: The study consisted of a systematic review and meta-analysis based on the analysis of indexed articles. The searches were carried out with the terms: “acute lymphoblastic leukemia”, “CAR T”, and “CD19-specific chimeric antigen receptor”. Results: Only 18 of the 94 articles obtained initially met the inclusion criteria and were selected for review, totaling 637 patients. Thus, it was observed in the responses that approximately 81% of the patients achieved a Complete Response; 7% did not respond; the neoplasm relapsed in 17% of the cases; and 6.1% of the patients died. The main side effects found were Cytokine Release Syndrome (CRS), Severe Cytokine Release Syndrome, and Neurotoxicity, present in 36.3%, 29%, and 24% of patients, respectively. Conclusion: Anti-CD19 CAR T-Cells immunotherapy is an effective therapy, capable of producing high rates of complete remission in R/R ALL treatment.

  • Surgical approaches and techniques in cancer treatment: past, present, and future/ Abordagens e técnicas cirúrgicas no tratamento oncológico: passado, presente e futuro

    by Isadora de Felix Pereira Bibas, Felipe Storm Ross, Ricardo Pasquini Neto, Jéssica Heloise Camargo de Lima, Marina Guimarães Gunther, João Gabriel Vicentini Karvat, Maria Cristina Figueroa Magalhães, Vinícius Basso Preti

    Introduction: Oncological surgery is one of the main pillars in the cancer treatment. Despite the significant advances of immunotherapies, target therapies, chemotherapies, and radiotherapies, surgery continues as an essential therapy. Objective: to present an updated overview of the oncological surgery’s role, highlighting its evolution throughout history and the current approaches and techniques in cancer treatment. Methods: Narrative and exploratory bibliographic study. The research was carried out in the Medline and Embase databases, using the terms (((surgical oncology)) OR ((surgery) AND (cancer) OR (tumors))). Results: Oncological surgery has made significant advances over its history. Currently, what prevails is the minimally invasive mentality with the techniques of video laparoscopy and robotic surgery. Although access is not uniform throughout the world, the expectation is that more popularization of these techniques will occur in the coming years. The oncological surgery is indicated to prevent, diagnose, evaluate the disease’s spread, curative treatment, sequelae and complications management, as well as palliation. Conclusion: Surgery is a procedure that improves the quality of life and increases cancer patients’ survival. The knowledge of its applicability, different techniques, and future expectations is essential for the correct orientation, referral to specialists, and patient’s follow-up.

  • Open Access

    COVID-19 cutaneous manifestations in children and adolescents: a systematic review

    by Ricardo Pasquini Neto, Felipe Antonio Torres Mazzo, Fernanda de Almeida Vieira, Gustavo de Souza Bueno, João Vitor Correa Previdi, Lara Rozetti da Silva, Nasthia Kreuz Baziulis da Silva, Joseph Lucius Jorizzo, Felipe Bochnia Cerci

    Objective: The aim of this study was to evaluate the coronavirus disease 2019 (COVID-19) cutaneous manifestations described in pediatric patients and discuss their relevance for early diagnosis. Data source: The study consisted of a systematic review of original articles indexed in PubMed and Embase databases, as well as gray literature articles found through Google Scholar. A search strategy, based on PICO (Patient, Intervention, Comparison, Outcome) Tool, with the terms “child,” “infant,” “childhood,” “adolescents,” “teenagers,” “COVID-19,” “SARS-CoV-2,” and “skin manifestations,” was performed to optimize the findings. The study did not restrict any article regarding language. Data synthesis: Out of the 310 articles that initially met the inclusion criteria, 35 were selected for review, totalizing 369 patients. The most common COVID-19 cutaneous manifestations in children and adolescents were Chilblain-like lesions, presented in 67.5% of the cases, followed by erythema multiforme-like (31.7%) and varicella-like lesions (0.8%). The Chilblain-like lesions appeared 7.6 days (95%CI 7.4–7.8) after the viral infection and lasted for 17.5 days (95%CI 16.5–18.5), erythema multiforme-like lesions appeared in 9.5 days (95%CI 9–10) and lasted for 10.3 days (95%CI 9.1–11.5), and varicella-like lesions appeared in 12.3 days (95%CI 4–20.6) and lasted for 7 days. Conclusions: Knowledge of the different skin manifestations in children and adolescents with COVID-19 is essential for an early diagnosis and, consequently, the possibility of promptly care adoption as well as to interrupt the new coronavirus transmission chains in the current pandemic context.


  • Open Access

    Manifestações cutâneas da COVID-19 em crianças e adolescentes: uma revisão sistemática

    by Ricardo Pasquini Neto, Felipe Antonio Torres Mazzo, Fernanda de Almeida Vieira, Gustavo de Souza Bueno, João Vitor Correa Previdi, Lara Rozetti da Silva, Nasthia Kreuz Baziulis da Silva, Joseph Lucius Jorizzo, Felipe Bochnia Cerci

    RESUMO Objetivo: Avaliar as manifestações cutâneas da Doença de Coronavírus 2019 (COVID-19) descritas em pacientes pediátricos e discutir sua relevância para o diagnóstico precoce. Fontes de dados: O estudo consistiu em uma revisão sistemática de artigos originais indexados nas bases de dados PubMed e Embase, assim como na literatura cinzenta localizados via Google Scholar. Uma estratégia de busca, baseada na PICO (Patient, Intervention, Comparison, Outcome) Tool, com os termos “child”, “infant”, “childhood”, “adolescents”, “teenagers”, “COVID-19”, “SARS-CoV-2” e “skin manifestations” foi conduzida para otimizar os achados. Não houve restrições de idiomas. Síntese de dados: 35 dos 310 artigos que inicialmente cumpriram os critérios de inclusão foram selecionados para revisão, totalizando 369 pacientes. As manifestações cutâneas mais comuns de COVID-19 em crianças e adolescentes foram as lesões Chilblain-Like presentes em 67,5% dos casos, seguidas pelas lesões Eritema Multiforme-Like (31,7%) e Varicella-Like (0,8%). As lesões Chilblain-Like surgiram 7,6 dias (IC95% 7,4–7,8) após a infecção viral e tiveram duração de 17,5 dias (IC95% 16,5–18,5); as lesões Eritema Multiforme-Like surgiram em 9,5 dias (IC95% 9–10) e duraram 10,3 dias (IC95% 9,1–11,5) e as lesões Varicella-Like apareceram em 12,3 dias (IC95% 4–20,6) e duraram 7 dias. Conclusões: O conhecimento das diferentes manifestações cutâneas em crianças e adolescentes com COVID-19 é essencial para o diagnóstico precoce da doença, assim como possibilitar adoção de prontos cuidados e interromper cadeias de transmissão do novo coronavírus.